English
Specials
    Upgrade

    Moneycontrol

    Budget 2023Budget 2023
    Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
    you are here: HomeNewsOpinion

    Gland Pharma’s streak of weak results should worry pharma investors

    The stock’s valuation has compressed from around 40 times FY21 earnings to about 23 times the FY23 earnings estimated figure

    R. Sree Ram
    January 25, 2023 / 09:35 AM IST
    Gland Pharma’s streak of weak results should worry pharma investors

    Highlights Annual revenues may drop for the first time since its listing The company is facing supply chain constraints for a year now with the issues yet to be resolved fully Competitive intensity increased in the US market and new products' scale-up is lagging expectations Growth rates may languish in the near term. New initiatives still in scale-up stage Gland Pharma’s revenue dropped for the third consecutive quarter in the December 2022 quarter, sending its shares to a new 52-week low on Tuesday. Revenue...

    • PRO Panorama

      Moneycontrol Pro Panorama | Equity traders get the rough end of the stick

      Jan 27, 2023 / 04:57 PM IST

      In today’s edition of Moneycontrol Pro Panorama: Should investors worry about turnover ratio, can banks pull up Nifty, problems ...

      Read Now

    To read the full story, Subscribe to Moneycontrol PRO

    Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

    View Plans

    Already a member? Sign in

    Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

    50% OFF

    What Do You Get

    • Ad free experience

      Experience a non-intrusive navigation and faster response in the ad free mode

    • Sharpest Opinions

      Access to 230+ exclusive stories per month from our editorial and Experts

    • +

      Have a Global edge with access to content from world renowned experts and journalist

    • Actionable Insights

      Access to 40+ weekly investment ideas including 4 daily technical calls

    • Virtual Events

      Exclusive access to live webinars from market experts on trading and investment strategies

    • Newsletters

      Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

    View Offers

    Get upto 50% discount on limited period offers